"Analysts were keen to hear how the pure-play lithium producer...

"Analysts were keen to hear how the pure-play lithium producer planned to spend the significant cash balance it has amassed since 2022."

"It’s most likely that the best investment’s back into the base asset, in terms of capital return, plus risk profile . . . that’s really the key prioritisation. So we’ll continue as we’re doing to invest in the base,” Dale Henderson said."

“That being said, we are considering and looking at inorganic growth opportunities, but we’re in no rush, and we won’t grow for growth’s sake. But if there’s a great opportunity . . . where we can create some great value for our shareholders we’re up for it.”

Holding onto cash proved a smart move last year when spodumene concentrate prices plunged.

Probably the same analysts who were bleating on about cash bleeds a week ago.

Seriously. Gonna need a smarter analyst.